Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | HPGD | P15428 | 3/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.57 |
| ▸ | RECQL | P46063 | 3/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.57 |
| ▸ | EGFR | P00533 | 2/20 | 0.57 |
| ▸ | CA2 | P00918 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | FYN | P06241 | 2/20 | 0.57 |
| ▸ | MMP9 | P14780 | 2/20 | 0.57 |
| ▸ | PIM1 | P11309 | 1/20 | 0.57 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | MMP2 | P08253 | 1/20 | 0.57 |
| ▸ | MMP8 | P22894 | 1/20 | 0.57 |
| ▸ | CA6 | P23280 | 1/20 | 0.57 |
| ▸ | CDK2 | P24941 | 1/20 | 0.57 |
| ▸ | MMP12 | P39900 | 1/20 | 0.57 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29373601 | 1.00 | ALDH1A1 (0.57) | ALDH1A1HPGDALOX15RECQLHSD17B10 | |
| Hydrochloric Acid SCHEMBL21799214 | 0.95 | ALDH1A1 (0.53) | ALDH1A1HPGDALOX15RECQLHSD17B10 | |
| Hydrochloric Acid SCHEMBL28771575 | 0.95 | ALDH1A1 (0.53) | ALDH1A1HPGDALOX15RECQLHSD17B10 | |
| Formaldehyde SCHEMBL12802314 | 0.88 | SELL (0.52) | ALDH1A1HPGDALOX15RECQLHSD17B10 | |
| Methoxymethane SCHEMBL28772216 | 0.84 | ALDH1A1 (0.50) | ALDH1A1HPGDALOX15RECQLHSD17B10 | |
| SCHEMBL29737462 | 0.84 | ALDH1A1 (0.44) | ALDH1A1HPGDALOX15RECQLHSD17B10 | |
| SCHEMBL1883019 | 0.84 | ALDH1A1 (0.44) | ALDH1A1HPGDALOX15RECQLHSD17B10 | |
| Acetone SCHEMBL28847116 | 0.82 | SELL (0.55) | ALDH1A1HPGDALOX15RECQLHSD17B10 | |
| Formic Acid SCHEMBL2160835 | 0.82 | SELL (0.48) | ALDH1A1HPGDALOX15RECQLHSD17B10 | |
| SCHEMBL324636 | 0.79 | PIM1 (0.40) | ALDH1A1HPGDALOX15RECQLHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1325 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260130861-A1 | THERAPEUTIC NANOPARTICLES WITH ANTIOXIDANT AND IRON-CHELATION ACTIVITY | UNIVERSITY OF OREGON (US) | 2026-05-14 | — | — | US | claimed |
| US-20250362613-A1 | COMPOSITION AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2025-11-27 | — | — | US | claimed |
| US-20250304851-A1 | METHODS AND COMPOSITIONS USED IN CONTROLLING FORMATION SAND PRODUCTION, PROPPANT FLOWBACK, AND FINES MIGRATION | HALLIBURTON ENERGY SERVICES, INC | 2025-10-02 | — | — | US | claimed |
| WO-2025043301-A1 | METAL-BINDING COMPOUNDS AND METAL COMPLEXES, METHODS OF THEIR PREPARATION, AND USES IN THE COMPLEXING OF METAL IONS | QUEENSLAND UNIVERSITY OF TECHNOLOGY (AU) | 2025-03-06 | — | — | WO | claimed |
| US-20250011265-A1 | COMPOSITIONS AND METHODS FOR PRODUCTION OF ANTIMICROBIAL AGENTS FROM BIO-RENEWABLE FEEDSTOCKS | SOLUGEN, INC. (US) | 2025-01-09 | — | — | US | claimed |
| CN-119080422-A | Cement chromium remover and preparation method and application thereof | 山东中岩建材科技有限公司 | 2024-12-06 | — | — | CN | claimed |
| US-20240369929-A1 | COMPOSITION AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2024-11-07 | — | — | US | claimed |
| WO-2024206663-A1 | REACTIVE CAPSID PROTEIN ASSOCIATED MOLECULES | THE TRUSTEES OF INDIANA UNIVERSITY (US) | 2024-10-03 | — | — | WO | claimed |
| US-20230382944-A1 | NOVEL COCRYSTALS OF DEXAMETHASONE | VERSITECH LIMITED (CN) | 2023-11-30 | — | — | US | claimed |
| EP-4267123-A1 | METHODS FOR PRODUCING D-?-METHYLDOPA | ImmunoMolecular Therapeutics, Inc. (US) | 2023-11-01 | — | — | EP | claimed |
| EP-0510446-A1 | Negative-working radiation-sensitive composition and radiation-sensitive recording material produced therewith | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-10-28 | — | — | EP | claimed |
| EP-0206126-B1 | CO-VULCANIZABLE COMPOSITIONS OF FLUOROELASTOMERS HAVING IMPROVED CHEMICAL STABILITY | AUSIMONT S.p.A. (IT) | 1992-03-25 | — | — | EP | claimed |
| EP-0393901-A1 | Ink composition | ADGER KOGYO CO., LTD. (JP) | 1990-10-24 | — | — | EP | claimed |
| US-4885244-A | CONTACTING MICROORGANISM WITH SACCHARIDE IN POLYHYDRIC AROMATIC COMPOUND CONTAINING MEDIUM; HIGH MOLECULAR WEIGHT | MITSUBISHI RAYON CO., LTD. (JP) | 1989-12-05 | — | — | US | claimed |
| US-4831083-A | MOLDING MATERIALS COMPRISING FLUOROPOLYMER BLEND, DIPHENOLIC COMPOUND, PEROXY COMPOUND AND, AS A PROMOTER, AN AMMONIOUM, PHOSPHONIUM OR AMINOPHOSPHONIUM COMPOUND | AUSIMONT S.R.L. (IT) | 1989-05-16 | — | — | US | claimed |
| EP-0127318-B1 | CURABLE FLUOROPOLYMER COMPOSITION | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-04-01 | — | — | EP | claimed |
| EP-0206126-A2 | Co-vulcanizable compositions of fluoroelastomers having improved chemical stability | AUSIMONT S.p.A. (IT) | 1986-12-30 | — | — | EP | claimed |
| US-4379178-A | Fingerprinting system | DACTEK INTERNATIONAL, INC. (US) | 1983-04-05 | — | — | US | claimed |
| US-4255418-A | Anti-acne lotion | BAILEY FLORENCE H | 1981-03-10 | — | — | US | claimed |
| US-3933732-A | VINYLIDENE FLUORIDE COPOLYMER, CARBOXYLIC ACID ESTER OF 4,4'-SULFONYLDIPHENOL | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-01-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260130861-A1 | THERAPEUTIC NANOPARTICLES WITH ANTIOXIDANT AND IRON-CHELATION ACTIVITY | GPX1, TXN2, TFRC | ALDH1A1 1056/4885HPGD 1652/4885ALOX15 208/4885 |
| US-20230382944-A1 | NOVEL COCRYSTALS OF DEXAMETHASONE | NR3C1, CRH, NR3C2 | ALDH1A1 1946/4885HPGD 514/4885ALOX15 953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.